Evidence map›Paper›PMID 41766653›Full record

ReviewJournal of hypertension2026

Effects and mechanisms of probiotics supplement on hypertension.

Zhe Jiang, Changlin Zhai, Chaojie He, Liang Shen, Guanmin Tang, Lijia Xu, Haojie Yang, Huilin Hu, Jungang Han

Abstract readReview
In one paragraph

Review in Journal of hypertension, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Zhe JiangDepartment of Cardiology, The First Hospital of Jiaxing Affiliated Hospital of Jiaxing University.
Changlin ZhaiDepartment of Cardiology, The First Hospital of Jiaxing Affiliated Hospital of Jiaxing University.
Chaojie HeDepartment of Cardiology, The First Hospital of Jiaxing Affiliated Hospital of Jiaxing University.
Liang ShenDepartment of Cardiology, The First Hospital of Jiaxing Affiliated Hospital of Jiaxing University.
Guanmin TangDepartment of Cardiology, The First Hospital of Jiaxing Affiliated Hospital of Jiaxing University.
Lijia XuDepartment of Cardiology, Jiaxing University Master Degree Cultivation Base, Zhejiang Chinese Medical University, 310053 Hangzhou, Zhejiang, China.
Haojie YangDepartment of Cardiology, Jiaxing University Master Degree Cultivation Base, Zhejiang Chinese Medical University, 310053 Hangzhou, Zhejiang, China.
Huilin HuDepartment of Cardiology, The First Hospital of Jiaxing Affiliated Hospital of Jiaxing University.
Jungang HanDepartment of Cardiology, The First Hospital of Jiaxing Affiliated Hospital of Jiaxing University.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The global population of individuals suffering from hypertension is estimated to surpass 1.28 billion. Uncontrolled hypertension makes contributions to the development of cardiovascular and cerebrovascular diseases. Emerging evidence indicates a significant correlation between hypertension and gut microbiota. As an intestinal regulator, which could confer health benefits to the host in adequate amounts, probiotics may become a novel approach to regulating blood pressure without side effects. Therefore, we overview the antihypertensive effects and the potential mechanisms of probiotics supplement on hypertension.

Indexed as

Dietary SupplementsHypertensionProbioticsAnimalsBlood PressureGastrointestinal MicrobiomeHumansgut microbiomehypertensionprobiotics supplement

Identifiers

PMID41766653
PMCPMC13034766

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.